2m 2m 2m 2m 2m 2m 2m
IronwoodPharma-A (IRWD)
NASDAQ
$3.22-$0.06 (-1.74%)
Price as of Jun 03, 2026 8:00 PM EDT- $587.7MMarket Cap
- 437.79%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
IronwoodPharma-A (IRWD)
$3.22-$0.06 (-1.74%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 296.2M -15.72% | 351.4M -20.63% | 442.7M +7.83% | 410.6M -0.76% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | 3.1M 0.00% | |
Gross Profit | 296.2M -15.72% | 351.4M -20.63% | 442.7M +8.66% | 407.5M -0.77% | |
Sales and Marketing Expense | 82.3M -42.99% | 144.3M -8.87% | 158.3M +36.48% | 116.0M +4.37% | |
Research and Development Expense | -95.1M -14.62% | -111.4M -4.02% | -116.1M +162.25% | -44.3M -37.13% | |
Depreciation and Amortization Expense | 1.9M -6.46% | 2.0M +27.68% | 1.6M +11.07% | 1.4M -6.89% | |
Total Operating Expenses | 197.6M -23.48% | 258.3M -81.39% | 1.4B +766.20% | 160.3M -11.70% | |
Operating Profit | 98.5M +5.78% | 93.1M +109.85% | -945.4M -477.66% | 250.3M +7.78% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | 24,000 0.00% | |
Interest Expense | -3.7M -23.20% | -4.8M -77.78% | -21.6M +184.67% | -7.6M -75.61% | |
Interest Income and Expense and Net | -3.7M -23.20% | -4.8M -77.78% | -21.6M +185.57% | -7.6M -75.67% | |
Total Nonoperating Income and Expense | -28.5M +1.97% | -27.9M +958.20% | -2.6M -226.57% | 2.1M +106.60% | |
Income before Taxes | 70.0M +7.40% | 65.2M +106.88% | -948.1M -475.59% | 252.4M +25.80% | |
Income Taxes | 46.0M -28.47% | 64.3M -22.96% | 83.5M +7.93% | 77.4M +123.60% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 24.0M +2,629.20% | 880,000 +100.09% | -1.0B -672.50% | 175.1M -66.87% | |
Net Income from Continuing Operations Applicable to Common | 70.0M +7.40% | 65.2M +106.88% | -948.1M -475.59% | 252.4M +25.80% | |
Basic EPS and Net Income | 0.15 +1,400.00% | 0.01 +100.16% | -6.45 -670.80% | 1.13 -65.34% | |
Diluted EPS and Net Income | 0.15 +1,400.00% | 0.01 +100.16% | -6.45 -771.87% | 0.96 -70.09% | |
Basic Weighted Average Shares | 161.8M +1.73% | 159.1M +2.35% | 155.4M +0.69% | 154.4M -4.86% | |
Diluted Weighted Average Shares | 163.0M +1.81% | 160.1M +2.99% | 155.4M -16.57% | 186.3M +13.32% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 215.5M +143.29% | 88.6M -3.90% | 92.2M -85.96% | 656.2M +5.82% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 215.5M +143.29% | 88.6M -3.90% | 92.2M -85.96% | 656.2M +5.82% | |
Total Current Assets | 274.2M +50.34% | 182.4M -21.83% | 233.3M -70.12% | 780.6M +4.75% | |
Accumulated Depreciation | 8.0M -4.30% | 8.4M -5.89% | 8.9M -17.42% | 10.8M +11.80% | |
Property and Plant and Equipment and Net | 3.4M -24.18% | 4.5M -19.52% | 5.6M -11.18% | 6.3M -16.99% | |
Total Long-Term Assets | 4.5M -23.99% | 5.9M +64.16% | 3.6M +325.97% | 847,000 -15.30% | |
Total Assets | 396.9M +13.11% | 350.9M -25.51% | 471.1M -57.20% | 1.1B -2.34% | |
Income Taxes Payable | 927,000 +77.93% | 521,000 -58.12% | 1.2M N/A | N/A N/A | |
Total Short-Term Debt | 199.7M +0.06% | 199.6M 0.00% | 199.6M +70.77% | 116.9M 0.00% | |
Total Current Liabilities | 242.2M +523.53% | 38.8M -85.93% | 276.1M +981.69% | 25.5M -84.21% | |
Total Long-Term Debt | 584.0M 0.00% | 584.0M +17.19% | 498.3M +25.76% | 396.3M +17.47% | |
Total Long-Term Liabilities | 21.6M +26.56% | 17.1M -39.80% | 28.4M +190.96% | 9.8M +178.95% | |
Total Liabilities | 252.1M +392.84% | 51.1M -82.40% | 290.6M +589.97% | 42.1M -76.62% | |
Retained Earnings | -1.7B -1.41% | -1.7B -0.05% | -1.7B +143.92% | -696.4M -25.73% | |
Total Stockholders Equity | -261.8M -13.11% | -301.3M -12.98% | -346.3M -153.08% | 652.4M +7.67% | |
Total Shares Outstanding | 163.1M +1.78% | 160.2M +2.46% | 156.4M +1.51% | 154.0M -4.94% | |
Cash Flow | |||||
Cash from Operating Activities | 127.0M +22.69% | 103.5M -43.55% | 183.4M -33.00% | 273.8M +4.53% | |
Capital Expenditures | 34,000 -76.06% | 142,000 -47.99% | 273,000 +100.74% | 136,000 -48.68% | |
Cash from Investing Activities | -34,000 -76.06% | -142,000 -99.99% | -1.0B +754,545.59% | -136,000 -48.68% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 216,000 +100.20% | -107.0M -138.60% | 277.2M +216.67% | -237.6M +5,120.95% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | 99.24% -0.006% | |
Operating Margin | 33.26% +25.51% | 26.50% +112.41% | -213.54% -450.25% | 60.97% +8.61% | |
Return on Assets | 6.42% +2,900.14% | 0.21% +100.17% | -127.54% -911.41% | 15.72% -74.92% | |
Return on Equity | -8.53% +3,038.04% | -0.27% -99.96% | -654.88% -2,453.49% | 27.83% -82.40% | |
Revenue Growth | -15.72% -23.77% | -20.63% -363.53% | 7.83% +1,125.87% | -0.76% -112.27% | |
Current Ratio | 1.13 -75.89% | 4.69 +455.64% | 0.84 -97.24% | 30.58 +563.59% | |
Cash Ratio | 0.89 -60.98% | 2.28 +582.95% | 0.33 -98.70% | 25.71 +570.34% | |
Debt-to-Equity Ratio | -2.99 +15.10% | -2.60 +29.03% | -2.02 -356.22% | 0.79 +4.92% | |
Debt-to-Assets Ratio | 1.97 -11.57% | 2.23 +50.73% | 1.48 +217.76% | 0.47 +15.68% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow